Citizens cuts AMERISAFE price target to $35 from $40, keeps Outperform
Citizens keeps its Market Outperform rating on AMERISAFE but lowers the price target to $35 from $40. The new target implies 38.3% upside from the Oct 28 close.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
Analyst firm Citizens kept its Market Outperform rating on AMERISAFE shares but reduced the price target to $35 from $40, a cut of 12.5%. According to TradingView, citing Benzinga data, the new target implies potential upside of 38.3% from the October 28 close of $25.30.
The report also notes that the material is not a personal recommendation and does not constitute investment advice.
why it matters
This revision concerns the analyst's valuation rather than news about the company's business, and the report does not give reasons for the cut. When a rating stays unchanged while the target falls, it usually signals an adjustment to expectations for the share price rather than a change in overall view. For the market, the signal is local and limited to a single stock.
tags
instruments
sources
- Citizens maintains AMERISAFE at Market Outperform, lowers price target to $35 from $40 — TradingView, 29 October 2026 at 15:20 UTC
- Citizens maintains DBV Technologies at Market Outperform, lowers price target to $47 from $55 — TradingView, 29 October 2026 at 15:25 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗